DK0788355T3 - Anvendelse af intravenøst indgiveligt jern til behandling af tumorsygdomme og/eller infektionssygdomme - Google Patents

Anvendelse af intravenøst indgiveligt jern til behandling af tumorsygdomme og/eller infektionssygdomme

Info

Publication number
DK0788355T3
DK0788355T3 DK95918533T DK95918533T DK0788355T3 DK 0788355 T3 DK0788355 T3 DK 0788355T3 DK 95918533 T DK95918533 T DK 95918533T DK 95918533 T DK95918533 T DK 95918533T DK 0788355 T3 DK0788355 T3 DK 0788355T3
Authority
DK
Denmark
Prior art keywords
diseases
intravenously administered
treatment
infectious diseases
administered iron
Prior art date
Application number
DK95918533T
Other languages
Danish (da)
English (en)
Inventor
Freiherr Von Nagell Helmut Rau
Original Assignee
Freiherr Von Nagell Helmut Rau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Freiherr Von Nagell Helmut Rau filed Critical Freiherr Von Nagell Helmut Rau
Application granted granted Critical
Publication of DK0788355T3 publication Critical patent/DK0788355T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95918533T 1994-06-01 1995-05-17 Anvendelse af intravenøst indgiveligt jern til behandling af tumorsygdomme og/eller infektionssygdomme DK0788355T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4419256A DE4419256A1 (de) 1994-06-01 1994-06-01 Verwendung von intravenös applizierbarem Eisen zur Therapie von Tumorerkrankungen und/oder Infektionskrankheiten
PCT/DE1995/000665 WO1995032711A1 (fr) 1994-06-01 1995-05-17 Utilisation de fer administrable par voie intraveineuse pour le traitement d'affections tumorales et/ou de maladies infectieuses

Publications (1)

Publication Number Publication Date
DK0788355T3 true DK0788355T3 (da) 2000-03-20

Family

ID=6519591

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95918533T DK0788355T3 (da) 1994-06-01 1995-05-17 Anvendelse af intravenøst indgiveligt jern til behandling af tumorsygdomme og/eller infektionssygdomme

Country Status (8)

Country Link
EP (1) EP0788355B1 (fr)
AT (1) ATE184790T1 (fr)
AU (1) AU2444695A (fr)
DE (2) DE4419256A1 (fr)
DK (1) DK0788355T3 (fr)
ES (1) ES2137513T3 (fr)
GR (1) GR3031505T3 (fr)
WO (1) WO1995032711A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19600744A1 (de) * 1996-01-11 1997-07-17 Werner Alois Prof Dipl Kaiser Magnetische Substanz zur lokalen hyperthermischen Behandlung vorwiegend kleiner Tumore

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2527158A1 (de) * 1975-06-18 1976-12-23 Herz Eberhard Arzneimittel zur behandlung von infektionskrankheiten und von nicht nachweisbar durch mikroorganismen ausgeloeste entzuendungen in der human- und veterinaermedizin
CH625125A5 (en) * 1975-09-26 1981-09-15 Biokema Sa Method for manufacturing a stable injectable solution of immunoglobulins and organic iron, and product obtained by this method
JPS6039681B2 (ja) * 1976-01-01 1985-09-07 日本臓器製薬株式会社 デキストリン・クエン酸・第二鉄多核複合体及び該複合体を含有する非経口用鉄剤
GB1546177A (en) * 1976-11-19 1979-05-16 Biokema Sa Process for the preparation of a stable injectable solution
GB2024007B (en) * 1978-06-30 1983-04-27 Gordon R T Cancer-treating composition containing inductively heatable particles
EP0227593A1 (fr) * 1985-11-25 1987-07-01 The Hospital For Sick Children Application d'agents chélatants
GB8607137D0 (en) * 1986-03-21 1986-04-30 Efamol Ltd Compositions
JP2648329B2 (ja) * 1987-09-18 1997-08-27 エフ・ホフマン−ラ ロシュ アーゲー エイズの予防または治療用医薬組成物
DE3842143A1 (de) * 1988-12-15 1990-06-21 Nitsche Dietrich Verwendung von transferrin zur endotoxinneutralisation
WO1990007322A1 (fr) * 1988-12-19 1990-07-12 David Gordon Diagnostic et traitement d'effets viraux
DE4117782C2 (de) * 1991-05-28 1997-07-17 Diagnostikforschung Inst Nanokristalline magnetische Eisenoxid-Partikel, Verfahren zu ihrer Herstellung sowie diagnostische und/oder therapeutische Mittel
FR2677885B1 (fr) * 1991-06-20 1994-08-26 Rocher Labo Biolog Vegetale Y Composition a base de plantes, utilisable en cosmetologie, en hygiene ou en pharmacie et son procede de preparation.
JP3100005B2 (ja) * 1992-07-28 2000-10-16 雪印乳業株式会社 ヒト免疫不全ウィルス感染・増殖抑制剤

Also Published As

Publication number Publication date
DE59506911D1 (de) 1999-10-28
AU2444695A (en) 1995-12-21
ATE184790T1 (de) 1999-10-15
EP0788355B1 (fr) 1999-09-22
GR3031505T3 (en) 2000-01-31
ES2137513T3 (es) 1999-12-16
WO1995032711A1 (fr) 1995-12-07
DE4419256A1 (de) 1995-12-07
EP0788355A1 (fr) 1997-08-13

Similar Documents

Publication Publication Date Title
DK0502092T3 (da) Oralt præparat til behandling af inflammatoriske tarmsygdomme
TW286283B (fr)
DE69333321D1 (de) Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten.
DK1169059T3 (da) Docetaxel i kombination med rhuMAb HER2 til behandling af cancere
DE69426334D1 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
BG106171A (en) Compositions and uses of et743 for treating cancer
DE69821498D1 (de) Verwendung von amifostin
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
MD990258A (en) Method of treatment of the acute viral hepatitis B
AP9801286A0 (en) Therapeutic compounds.
ATE372774T1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
ATE291918T1 (de) Kombinationstherapie zur behandlung von tumoren
DK0788355T3 (da) Anvendelse af intravenøst indgiveligt jern til behandling af tumorsygdomme og/eller infektionssygdomme
ATE345805T1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
ATE385798T1 (de) Pharmazeutische zubereitungen enthaltend azd 2171 und zd 6126 und verwendungen
ATE293983T1 (de) Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.
DK1150981T3 (da) Terapeutisk necleosidforbindelse
UA36756A (uk) Спосіб лікування хворих із злоякісними пухлинами молочної залози
UA40393A (uk) Спосіб лікування хронічного обструктивного бронхіту
DE60121449D1 (de) Behandlung von hepatitis c mit thymosin und pegyliertem interferon
UA32914A (uk) Спосіб лікування цереброваскулярної патології